CN111172049A - Toxoflavin high-yield strain and application thereof - Google Patents
Toxoflavin high-yield strain and application thereof Download PDFInfo
- Publication number
- CN111172049A CN111172049A CN201811328269.7A CN201811328269A CN111172049A CN 111172049 A CN111172049 A CN 111172049A CN 201811328269 A CN201811328269 A CN 201811328269A CN 111172049 A CN111172049 A CN 111172049A
- Authority
- CN
- China
- Prior art keywords
- burkholderia
- toxoflavin
- culture
- hdxy
- culture medium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- SLGRAIAQIAUZAQ-UHFFFAOYSA-N toxoflavin Chemical compound CN1N=CN=C2C1=NC(=O)N(C)C2=O SLGRAIAQIAUZAQ-UHFFFAOYSA-N 0.000 title claims abstract description 189
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims abstract description 66
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims abstract description 42
- 238000000855 fermentation Methods 0.000 claims abstract description 38
- 230000004151 fermentation Effects 0.000 claims abstract description 38
- 239000001963 growth medium Substances 0.000 claims abstract description 32
- 239000007787 solid Substances 0.000 claims abstract description 31
- 238000000034 method Methods 0.000 claims abstract description 20
- 241001453380 Burkholderia Species 0.000 claims abstract description 17
- 241001225321 Aspergillus fumigatus Species 0.000 claims abstract description 14
- 229940091771 aspergillus fumigatus Drugs 0.000 claims abstract description 13
- 238000004321 preservation Methods 0.000 claims abstract description 5
- 244000052616 bacterial pathogen Species 0.000 claims abstract description 4
- 238000009629 microbiological culture Methods 0.000 claims abstract description 3
- 239000007788 liquid Substances 0.000 claims description 21
- 238000000605 extraction Methods 0.000 claims description 14
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 12
- 238000001035 drying Methods 0.000 claims description 12
- 239000012074 organic phase Substances 0.000 claims description 11
- 239000000287 crude extract Substances 0.000 claims description 10
- 239000000284 extract Substances 0.000 claims description 10
- 239000002609 medium Substances 0.000 claims description 10
- 239000006228 supernatant Substances 0.000 claims description 8
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 7
- 239000003960 organic solvent Substances 0.000 claims description 5
- 238000011218 seed culture Methods 0.000 claims description 5
- 230000012010 growth Effects 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 238000000746 purification Methods 0.000 claims description 4
- 238000007790 scraping Methods 0.000 claims description 4
- 238000002791 soaking Methods 0.000 claims description 4
- 238000010828 elution Methods 0.000 claims description 3
- 238000011081 inoculation Methods 0.000 claims description 2
- 230000008569 process Effects 0.000 claims description 2
- 238000010898 silica gel chromatography Methods 0.000 claims description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims 2
- 241000134107 Burkholderia plantarii Species 0.000 claims 1
- 239000008346 aqueous phase Substances 0.000 claims 1
- 210000001072 colon Anatomy 0.000 claims 1
- 238000012136 culture method Methods 0.000 claims 1
- 244000005700 microbiome Species 0.000 abstract description 6
- 206010028980 Neoplasm Diseases 0.000 abstract description 5
- 230000000694 effects Effects 0.000 abstract description 5
- 230000002401 inhibitory effect Effects 0.000 abstract description 4
- 239000000126 substance Substances 0.000 abstract description 4
- 238000009630 liquid culture Methods 0.000 abstract description 2
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- 241001508395 Burkholderia sp. Species 0.000 description 33
- 210000004027 cell Anatomy 0.000 description 13
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 9
- 238000012258 culturing Methods 0.000 description 8
- 239000001888 Peptone Substances 0.000 description 7
- 108010080698 Peptones Proteins 0.000 description 7
- 235000019319 peptone Nutrition 0.000 description 7
- 229920001817 Agar Polymers 0.000 description 6
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 6
- 239000008272 agar Substances 0.000 description 6
- 238000001514 detection method Methods 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 239000003242 anti bacterial agent Substances 0.000 description 4
- 235000015278 beef Nutrition 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- 241000222122 Candida albicans Species 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- 239000002246 antineoplastic agent Substances 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 229940095731 candida albicans Drugs 0.000 description 3
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 3
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 3
- 235000019341 magnesium sulphate Nutrition 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 230000002194 synthesizing effect Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 238000004809 thin layer chromatography Methods 0.000 description 3
- 241000351920 Aspergillus nidulans Species 0.000 description 2
- 206010009944 Colon cancer Diseases 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- 241001052560 Thallis Species 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000003385 bacteriostatic effect Effects 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 238000005660 chlorination reaction Methods 0.000 description 2
- 208000029742 colonic neoplasm Diseases 0.000 description 2
- 230000003013 cytotoxicity Effects 0.000 description 2
- 231100000135 cytotoxicity Toxicity 0.000 description 2
- 230000035784 germination Effects 0.000 description 2
- 238000001819 mass spectrum Methods 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 238000006396 nitration reaction Methods 0.000 description 2
- 230000004763 spore germination Effects 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- OTLLEIBWKHEHGU-UHFFFAOYSA-N 2-[5-[[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy]-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,5-dihydroxy-4-phosphonooxyhexanedioic acid Chemical compound C1=NC=2C(N)=NC=NC=2N1C(C(C1O)O)OC1COC1C(CO)OC(OC(C(O)C(OP(O)(O)=O)C(O)C(O)=O)C(O)=O)C(O)C1O OTLLEIBWKHEHGU-UHFFFAOYSA-N 0.000 description 1
- RVBUGGBMJDPOST-UHFFFAOYSA-N 2-thiobarbituric acid Chemical compound O=C1CC(=O)NC(=S)N1 RVBUGGBMJDPOST-UHFFFAOYSA-N 0.000 description 1
- VQUOCQPUWMVVJV-UHFFFAOYSA-N 6-[amino(methyl)amino]-3-methyl-1h-pyrimidine-2,4-dione Chemical compound CN(N)C1=CC(=O)N(C)C(=O)N1 VQUOCQPUWMVVJV-UHFFFAOYSA-N 0.000 description 1
- 241001135516 Burkholderia gladioli Species 0.000 description 1
- 241000589638 Burkholderia glumae Species 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- XGEGHDBEHXKFPX-UHFFFAOYSA-N N-methylthiourea Natural products CNC(N)=O XGEGHDBEHXKFPX-UHFFFAOYSA-N 0.000 description 1
- 206010033128 Ovarian cancer Diseases 0.000 description 1
- 206010061535 Ovarian neoplasm Diseases 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 238000010170 biological method Methods 0.000 description 1
- 230000003570 biosynthesizing effect Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 238000010531 catalytic reduction reaction Methods 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000006059 cover glass Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000006193 diazotization reaction Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 229940023064 escherichia coli Drugs 0.000 description 1
- 239000002095 exotoxin Substances 0.000 description 1
- 231100000776 exotoxin Toxicity 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 150000002211 flavins Chemical class 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- XGEGHDBEHXKFPX-NJFSPNSNSA-N methylurea Chemical compound [14CH3]NC(N)=O XGEGHDBEHXKFPX-NJFSPNSNSA-N 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 229940056360 penicillin g Drugs 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000035806 respiratory chain Effects 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000028070 sporulation Effects 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
- C12P17/182—Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
The invention discloses a burkholderia capable of stably producing toxoflavin at high yieldBurkholderiasp.) HDXY-02, belonging to the technical field of applied microorganisms. The strain is preserved in China general microbiological culture Collection center (CGMCC for short) in 2017, 4 months and 20 days, and the preservation number is CGMCC No. 14054. After the liquid culture medium of the strain is fermented or the solid plate is coated and cultured for 48-72 hours, the toxoflavin obtained by extracting dichloromethane or chloroform, separating and purifying has the activity of inhibiting pathogenic bacteria aspergillus fumigatus and resisting tumor Lovo cells. The strain provided by the invention can synthesize toxoflavin through fermentation and has high yield, and compared with the existing chemical synthesis method, the method avoids the pollution of chemical substances to the environment and has potential application prospect.
Description
Technical Field
The invention relates to Burkholderia and application thereof, in particular to Burkholderia sp HDXY-02 capable of efficiently synthesizing toxoflavin, and belongs to the technical field of microorganisms.
Background
Natural products are substances produced by microorganisms, plants, or other organisms, wherein microbial natural products provide a rich source of chemical diversity. Toxoflavin is a small-molecular fatty acid exotoxin synthesized by microorganisms, and is found to be used as an antibacterial agent and an antitumor agent. The molecular formula of toxoflavin is C7H7N5O2The molar mass is 193g/mol, and the antibacterial agent can generate resistance to various pathogenic bacteria, and the strong antibacterial property of the antibacterial agent can be caused by inhibiting the respiratory chain and generating peroxide. The toxoflavin also has strong antitumor activity and can kill cancer cells at a lower concentration. Researches prove that the toxoflavin has good inhibitory activity on lung cancer cells, ovarian cancer cells, gastric cancer cells and other cancer cells. The higher biological activity of toxoflavin in the aspects of antibiosis, tumor resistance and the like indicates that toxoflavin has prospect in the research fields of pharmacology, toxicology and the like. The toxoflavin has high research value in the aspects of apoptosis and the like as a new antibiotic and antitumor drug. In addition, the development of post-structure modified toxoflavin as an antibacterial and antitumor agent drug also has high commercial value.
At present, toxoflavin can be synthesized chemically, 2-thiobarbituric acid is taken as a raw material, and the toxoflavin is synthesized through the steps of methylation, chlorination, hydrolysis, nitration, catalytic reduction, reflux and the like; can also be used for synthesizing toxoflavin by prolonging the nitration and cyclization of 3-methyl-6- (1' -methylhydrazino) uracil; in addition, the toxoflavin can be synthesized by using methylurea, malonic acid and acetic anhydride as raw materials through the steps of chlorination, condensation, diazotization and the like. However, the steps for chemically synthesizing toxoflavin are complex, the required organic reagents are more, the number of byproducts is large, the environment is polluted, and the like. It is worth noting that toxoflavin can be synthesized not only by chemical methods but also by biological methods. In natural environment, the microorganisms capable of producing toxoflavin include Pseudomonas cocoanut, Burkholderia gladioli, Burkholderia glumae and the like. The biosynthesis has the advantages of small pollution, mild reaction conditions and the like. But the yield of toxoflavin in microorganisms is low at present, and the yield of toxoflavin still has a great space to be improved. Therefore, the method has important research and development values for further obtaining the high-yield toxoflavin strain by separating the toxoflavin production strain in the environment, and is an important way for solving the limitation of the source of the current toxoflavin raw material.
Disclosure of Invention
The technical problem to be solved by the invention is as follows: aiming at the defects of the prior art, the Burkholderia sp (Burkholderia sp.) with high toxoflavin yield is provided, the strain is stable in heredity, and the content of toxoflavin in fermentation liquor is high.
The Burkholderia sp HDXY-02 strain is preserved in China general microbiological culture Collection center (CGMCC), the preservation unit address is No. 3 of Xilu No.1 of Beijing Korean district, the microbial research institute of Chinese academy of sciences, the preservation date is 4 months and 20 days in 2017, and the registration number of the strain is CGMCC No. 14054.
The invention aims to provide Burkholderia sp (HDXY-02) with high toxoflavin yield and application thereof, the bacterial strain has strong toxoflavin production capacity, the yield can reach 387mg/L after being cultured for 48 hours at 30 ℃, and good application prospects are shown.
The second purpose of the invention is to provide a method for biosynthesizing and extracting toxoflavin. The toxoflavin extracted by the invention is obtained by liquid fermentation or solid culture and then extraction of the Burkholderia sp.
Extraction of toxoflavin after liquid fermentation of Burkholderia sp.hdxy-02: inoculating a proper amount of activated and cultured strains into seed liquid, inoculating the strains into a liquid fermentation culture medium according to a certain proportion for fermentation after overnight culture, centrifuging after the fermentation is finished, taking supernatant of fermentation liquid, adding chloroform or dichloromethane for extraction, collecting an organic phase part, concentrating and volatilizing an organic solvent under reduced pressure, adding a little chloroform or dichloromethane for extracting residues once, drying to obtain a crude extract, and further purifying to obtain a pure toxoflavin.
Extraction of toxoflavin after solid culture of Burkholderia sp.hdxy-02: diluting a proper amount of activated and cultured strains, coating the strains on a KMB solid plate, scraping thalli on the surface of the plate after culture, soaking chloroform or dichloromethane in a solid culture medium for extraction, collecting an organic phase part, concentrating and volatilizing the chloroform or dichloromethane under reduced pressure, adding a little chloroform or dichloromethane to extract residues once, drying to obtain a crude extract, and further purifying to obtain a pure toxoflavin.
Detecting fermentation extract of Burkholderia sp.HDXY-02 by thin layer chromatography, liquid phase, mass spectrum and other methods, and confirming that main extract of fermentation liquor of Burkholderia sp.HDXY-02 is toxoflavin with molecular formula of C7H7N5O2The molecular weight is 193 g/mol.
Specifically, the preparation method of toxoflavin comprises the following steps:
(1) preparation of fermentation broth or culture plate
Fermentation liquor: inoculating Burkholderia sp.HDXY-02 as defined in claim 1 into LB culture medium, culturing overnight at 30 ℃, and obtaining seed liquid after culturing for 12-16 h; inoculating the seed liquid into a KMB fermentation culture medium in an inoculation amount of 1-10%, and performing shake culture at 200 rpm.
Culturing a flat plate: burkholderia sp.HDXY-02 according to claim 1 was inoculated into a seed medium (0.5% beef extract; 1% peptone; 0.5% NaCl; 2% agar; distilled water; pH7.0) by shaking culture for 24 hours, diluted appropriately, and spread uniformly on the surface of KMB solid medium.
(2) Preliminary purification of toxoflavin
Centrifuging the fermentation liquor obtained in the step (1), removing thalli, collecting supernatant, performing isometric extraction on the supernatant by using dichloromethane or chloroform as a solvent, collecting an organic phase, and drying to obtain a crude extract of toxoflavin; or scraping off thallus on the surface of the plate, cutting up the solid culture medium, soaking the solid culture medium in dichloromethane or chloroform as a solvent, collecting the organic phase, and drying to obtain the crude extract of toxoflavin.
(3) Secondary purification of toxoflavin
And (3) performing gradient elution on the crude extract obtained in the last step by adopting column chromatography, separating and purifying, and further recrystallizing twice by using n-butyl alcohol to obtain purified toxoflavin.
In the method of the present invention, it is preferable that the KMB medium used in the step (1) for culturing Burkholderia sp.HDXY-02 has the following composition: 20.0g of peptone, 1.5g of dipotassium phosphate, 0.75g of magnesium sulfate and 15mL of glycerol, wherein the pH value is 5.5-8.5, and the volume is up to 1000 mL. Agar was added to the solid medium to a final concentration of 1.5%.
In the method of the present invention, preferably, the culture temperature in step (1) is 30-35 ℃, and the culture is performed for 48-72 hours.
The biological activity detection result shows that: hdxy-02 can inhibit the growth of various pathogenic bacteria (escherichia coli, aspergillus fumigatus and candida albicans); meanwhile, the composition can inhibit Lovo cells of human colon cancer in a proper concentration range.
The method has the advantages that the toxoflavin is stably produced by the strain after multiple passages, and the capacity is not weakened. The Burkholderia sp.HDXY-02 provided by the invention can produce toxoflavin with high yield, and has potential industrial application prospect.
Drawings
FIG. 1 thin layer chromatography analysis of toxoflavin produced by Burkholderia sp.HDXY-02
FIG. 2 Mass Spectrometry (MS) analysis of toxoflavin produced by Burkholderia sp.HDXY-02
FIG. 3 shows the bacteriostatic test of toxoflavin produced by Burkholderia sp.HDXY-02
FIG. 4 inhibition of spore germination and spore formation of Aspergillus fumigatus by Burkholderia sp.HDXY-02 (A) and (B)
FIG. 5: effect of toxoflavin produced by Burkholderia sp.HDXY-02 on viability of cancer Lovo cells
Detailed Description
The present invention is further described below with reference to specific examples, which are only exemplary and do not limit the scope of the present invention in any way.
Example one extraction of toxoflavin by solid culture of Burkholderia sp.HDXY-02
1. Strain activation
The preserved Burkholderia sp.HDXY-02 strain is picked, streaked on a seed solid culture medium (0.5% beef extract, 1% peptone, 0.5% NaCl, 2% agar, distilled water, pH7.0), and cultured at a constant temperature of 30-35 ℃ for 48-72 h.
2. Solid plate culture
Burkholderia sp.HDXY-02 single colonies are picked and inoculated in a seed culture medium (0.5% beef extract, 1% peptone, 0.5% NaCl, 2% agar, distilled water and pH7.0), after shaking culture for 24 hours, diluted properly, coated on a KMB culture medium (20.0 g of peptone, 1.5g of dipotassium hydrogen phosphate, 0.75g of magnesium sulfate, 15mL of glycerol, pH 5.5-8.5, constant volume to 1000mL, 1.5% agar), and kept stand and cultured for 48-72 hours at a constant temperature of 30-35 ℃.
3. Extraction of toxoflavin
Scraping off lawn on the surface of the solid culture medium, chopping the solid culture medium rich in toxoflavin, adding 1/2 volume of chloroform or dichloromethane, shaking for 5-10 min, standing for 20-40 min, and removing the organic phase part. The same procedure was repeated 3 times by soaking the solid medium with chloroform or dichloromethane extraction. And combining the organic phases, and volatilizing the organic solvent in a rotary evaporator at 40-45 ℃. And adding a little chloroform or dichloromethane for extraction once, and drying in a drying oven at 40-45 ℃ to obtain a fermented crude extract.
Example two production of toxoflavin by liquid fermentation of Burkholderia sp.HDXY-02
1. Strain activation
The preserved Burkholderia sp.HDXY-02 strain is picked, streaked on a seed solid culture medium (0.5% beef extract, 1% peptone, 0.5% NaCl, 2% agar, distilled water, pH7.0), and cultured at a constant temperature of 30-35 ℃ for 48-72 h.
2. Liquid fermentation process
The Burkholderia sp.HDXY-02 strain on a seed culture medium is diluted and uniformly mixed by using normal saline, 1-10mL of overnight culture is absorbed and inoculated into a 250mL triangular flask filled with 100mL of KMB liquid culture medium (20.0 g of peptone, 1.5g of dipotassium hydrogen phosphate, 0.75g of magnesium sulfate, 15mL of glycerol, pH 5.5-8.5, constant volume to 1000mL), and the mixture is cultured for 48-72 hours at 30-35 ℃ at 150-200 rpm under continuous shaking.
3. Extraction of toxoflavin
And after the shaking culture is finished, centrifuging the fermentation liquor for 4-5 min at the temperature of 4-20 ℃ at 4000-6000 g, sucking the supernatant, adding 1/2 volume of chloroform or dichloromethane into the supernatant, shaking for 5-10 min, standing for 20-40 min, and removing the organic phase part. The same procedure was repeated 3 times by extracting the aqueous portion once with chloroform or dichloromethane. And combining the organic phases, and volatilizing the organic solvent in a rotary evaporator at 40-45 ℃. And adding a little chloroform or dichloromethane for extraction once, and drying in a drying oven at 40-45 ℃ to obtain a fermented crude extract.
EXAMPLE III toxoflavin detection
And (3) secondary purification of toxoflavin: separating and purifying the crude extract by silica gel column chromatography, wherein the gradient elution process comprises the following steps: (dichloromethane: methanol) 90:10 → 80:20 → 60:40 → 50:50 → 30:70 → 0:100 (v/v). And further recrystallizing twice through n-butanol to obtain purified toxoflavin.
The toxoflavin extracted from the strain is compared with a toxoflavin standard.
Thin layer chromatography: the fermentation broth extract of the strain and the standard toxoflavin were dissolved in the same volume of methanol, spotted on one end of a thin-layer silica gel G plate, and developed in a developing solvent (chloroform: methanol: water) (70:25:5, V/V), respectively (see FIG. 1).
Mass spectrum detection: the fermentation liquor extract produced by Burkholderia sp.HDXY-02 liquid fermentation has the same ion peak of 194.0714 m/z as that of the standard toxoflavin. The results show that the fermentation liquor extract for producing toxoflavin by liquid fermentation of Burkholderia sp.HDXY-02 is toxoflavin, and the specific molecular formula and the molecular weight are shown in figure 2.
EXAMPLE four passage verification of Burkholderia sp.HDXY-02 stability of toxoflavin production
Firstly, the Burkholderia sp.HDXY-02 preserved in a refrigerator is streaked on an LB solid culture medium, then after 24 hours of culture, the colonies are removed from the first solid culture medium and then are transplanted onto the second solid culture medium, and so on, ten generations of solid plate colonies are cultured. Respectively inoculating the above materials into seed culture medium, culturing overnight to obtain seed liquid, inoculating into fermentation culture medium, performing shake flask fermentation at 30 deg.C and 200rpm, and continuously shaking for 48 hr. The content of flavins in the fermentation supernatant was determined and the results are shown in Table 1.
TABLE 1 Burkholderia sp.HDXY-02 toxoflavin production passage stability test
As can be seen from the results in Table 1, after multiple passages, the production of toxoflavin by Burkholderia sp.HDXY-02 is stable, and the yield of toxoflavin is not reduced after 10 passages.
EXAMPLE five antimicrobial Activity of toxoflavin produced by Burkholderia sp.HDXY-02 fermentation
1. Detection of bacteriostatic activity
Test strains (Escherichia coli, Candida albicans, Aspergillus nidulans and Aspergillus fumigatus) were selected and diluted with physiological saline. Preparing a toxoflavin detection solution produced by Burkholderia sp.HDXY-02 liquid fermentation at a certain concentration, and adding the toxoflavin detection solution into a solid culture medium according to the concentration. A dilution gradient 106～108The bacterial liquid of CFU/mL thallus is cultured on YAG, YPDA and LB solid culture medium added with toxoflavin at the temperature of 37 ℃ for 24h, and whether the strain grows or not is observed. The results showed that toxoflavin produced by Burkholderia sp.HDXY-02 liquid fermentation had the ability to inhibit the growth of pathogens (FIG. 3). MIC values for Escherichia coli, Candida albicans, Aspergillus nidulans and Aspergillus fumigatus were 5mg/L, 100mg/L, 200mg/L and 100mg/L, respectively.
2. Effect of toxoflavin on spore germination and sporulation of Aspergillus fumigatus
Collecting Aspergillus fumigatus spores by using freshly cultured Aspergillus fumigatus, and adjusting the spore concentration to 10 with YAG or MM medium7CFU/mL, adding toxoflavin to a final concentration of 25 μ g/mL, adding dropwise onto a pre-sterilized cover glass, culturing at 37 deg.C for a corresponding time, taking out, observing with microscope, and collecting the liquid containing equal amount of spores without toxoflavinThe body medium served as a control. As shown in FIG. 4A, in the case of no toxoflavin, germination starts immediately after 6h of culture of Aspergillus fumigatus spores, but the spores are not germinated after 20h by the treatment with the toxoflavin, indicating that the toxoflavin can significantly inhibit the germination of Aspergillus fumigatus spores. The spore-forming structure is important for growth and propagation of aspergillus fumigatus, the final concentration of toxoflavin is selected to be 50 mug/mL, the toxoflavin is added into a solid YAG or MM culture medium, aspergillus fumigatus spores are inoculated, cultivation is carried out in an inserting mode, cultivation is carried out at 37 ℃ for proper time, and microscopic observation is carried out. Toxoflavin was found to significantly inhibit the formation of a sporulating structure of A.fumigatus (FIG. 4B).
EXAMPLE six cytotoxicity of toxoflavin produced by Burkholderia sp.HDXY-02 liquid fermentation
The cytotoxicity of toxoflavin produced by Burkholderia sp.HDXY-02 liquid fermentation on human colon cancer cells (Lovo) is detected by applying an MTT method.
1. Preparation of cell line culture
Culture medium: DMEM (Gibco, USA) supplemented with 10% inactivated calf serum and penicillin G (100U/mL). The Lovo cells were added to culture flasks containing 10mL of medium at 37 ℃ with 5% CO2The incubator (2) is used for moisture-keeping culture. Toxoflavin was dissolved in water and diluted to serial concentrations 5min before use in DMEM medium.
Test for detecting cell growth inhibition ability of toxoflavin by MTT method
To each experimental well of a 96-well cell culture plate, 100. mu.L (containing toxoflavin at the corresponding concentration) of 104Cell sap of Lovo cells, each concentration was set at five replicates, toxoflavin final concentrations of 5, 2.5, 1.25, 0.625, 0.3125 and 0.15625, with no toxoflavin control wells. 37 ℃ and 5% CO2And (5) carrying out moisture-preserving culture in an incubator with the concentration. Culturing under the same conditions for 24h, adding 20 μ l MTT (5mg/mL) into each well, culturing for 4h, carefully blotting the solution in each well, adding 100 μ l DMSO, shaking at 37 deg.C for 10min, selecting 570nm wavelength, and detecting the absorbance of each well with microplate reader. The data is obtained by adding and subtracting standard deviation from the average value of five wells, calculating the percentage of survival cells, and drawing a survival curve, the result is shown in figure 5, toxoflavin has obvious inhibition effect on Lovo cells, the inhibition rate and the concentration form positive correlation, and IC50The value was 0.43. mu.g/mL (2.226. mu.M).
Experimental data show that toxoflavin produced by Burkholderia sp.HDXY-02 liquid fermentation also has the obvious effect of inhibiting Lovo tumor cells.
Claims (5)
1. Burkholderia capable of stably producing toxoflavin at high yieldBurkholderiasp.) HDXY-02, which is preserved in China general microbiological culture Collection center (CGMCC for short) in 2017 in 20 months 4, and the preservation number is CGMCC number 14054.
2. A method of using the Burkholderia bacterium (B) of claim 1Burkholderiasp.) fermentation culture method for producing toxoflavin by HDXY-02, which is characterized in that Burkholderia with the preservation number of CGMCC No 14054 (Burkholderia plantarii: (CGMCC) number)Burkholderiasp.) HDXY-02 for liquid fermentation culture or solid plate culture:
(1) liquid fermentation: activated Burkholderia bacterium (b), (c), (d), (Burkholderiasp.) HDXY-02 is inoculated in a seed culture medium for overnight culture, and then is inoculated in a KMB fermentation culture medium with the inoculation amount of 1-10%, the culture condition is 30-35 ℃, 150-200 rpm, continuous shaking culture is carried out for 48-72 h, and the pH value of the culture medium is 5.5-8.5;
(2) solid plate culture: activated Burkholderia bacterium (b), (c), (d), (Burkholderiasp.) HDXY-02 is inoculated in a seed culture medium, after shaking culture is carried out for 24 hours, the mixture is diluted properly and coated on a KMB solid culture medium under the culture condition of 30-35 ℃ and is kept still for 48-72 hours at constant temperature.
3. Burkholderia (Burkholderia) according to claim 1Burkholderiasp.) method for extracting flavin from HDXY-02 fermentation broth, which is characterized by comprising the following steps: after the shaking culture is finished, centrifuging the fermentation liquor for 4-5 min at 4-20 ℃ at 4000-6000 g, sucking supernatant, adding 1/2 volume of chloroform or dichloromethane into the supernatant, shaking for 5-10 min, standing for 20-40 min, and removing an organic phase part; extracting the aqueous phase with chloroform or dichloromethane once, repeating for 3 times, and mixingAnd volatilizing the organic solvent in a rotary evaporator at 40-45 ℃, adding a little chloroform or dichloromethane for extraction once, and drying in a drying oven at 40-45 ℃ to obtain a fermented crude extract.
4. Burkholderia (Burkholderia) according to claim 1Burkholderiasp.) method for extracting flavin from HDXY-02 solid medium, characterized in that it is carried out by the following steps: scraping off lawn on the surface of the solid culture medium, chopping the solid culture medium rich in toxoflavin, adding 1/2 volume of chloroform or dichloromethane, shaking for 5-10 min, standing for 20-40 min, and removing an organic phase part; extracting and soaking the solid culture medium with chloroform or dichloromethane by the same method, repeating for 3 times, combining organic phases, volatilizing the organic solvent in a rotary evaporator at 40-45 ℃, adding a little chloroform or dichloromethane for extraction once, and drying in a drying oven at 40-45 ℃ to obtain a fermented crude extract.
5. Burkholderia (Burkholderia) according to claim 1Burkholderiasp.) the purification method of the crude toxoflavin extracted from the HDXY-02 fermentation liquor or solid culture is characterized by comprising the following steps: the crude toxoflavin extract is separated and purified by silica gel column chromatography, and the gradient elution process comprises the following steps: (dichloromethane: methanol) 90:10 → 80:20 → 60:40 → 50:50 → 30:70 → 0:100 (v/v); and further recrystallizing twice by n-butanol to obtain purified toxoflavin which can inhibit the growth of various pathogenic bacteria (including aspergillus fumigatus); can also inhibit Lovo cell, Ic of human colon cancer50It was 0.43. mu.g/mL (2.226. mu.M).
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811328269.7A CN111172049B (en) | 2018-11-09 | 2018-11-09 | Strain Huang Sugao producing strain and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811328269.7A CN111172049B (en) | 2018-11-09 | 2018-11-09 | Strain Huang Sugao producing strain and application thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN111172049A true CN111172049A (en) | 2020-05-19 |
| CN111172049B CN111172049B (en) | 2023-05-26 |
Family
ID=70645955
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811328269.7A Active CN111172049B (en) | 2018-11-09 | 2018-11-09 | Strain Huang Sugao producing strain and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111172049B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111172050A (en) * | 2018-11-09 | 2020-05-19 | 江苏省中国科学院植物研究所 | Fermentation strategy for high yield of toxoflavin by using Burkholderia |
| CN111662939A (en) * | 2020-07-24 | 2020-09-15 | 江苏省中国科学院植物研究所 | Method for promoting burkholderia to synthesize toxoflavin by using signal molecules |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20080051316A (en) * | 2006-12-05 | 2008-06-11 | 재단법인서울대학교산학협력재단 | Toxoflavin herbicide from burkholderia glumae and separation method thereof |
| JPWO2009060882A1 (en) * | 2007-11-09 | 2011-03-24 | 国立大学法人 東京大学 | Amide compounds and bacterial disease control agents for agriculture and horticulture |
| US20140073501A1 (en) * | 2010-02-25 | 2014-03-13 | Marrone Bio Innovations, Inc. | Isolated bacterial strain of the genus burkholderia and pesticidal metabolites therefrom |
| CN105319313A (en) * | 2015-12-09 | 2016-02-10 | 山东出入境检验检疫局检验检疫技术中心 | Liquid chromatogram-tandem mass spectrum detection method of toxoflavin |
| CN105907753A (en) * | 2016-05-25 | 2016-08-31 | 山东出入境检验检疫局检验检疫技术中心 | Burkholderia gladioli molecular standard sample and preparation method thereof |
| CN107099478A (en) * | 2017-06-06 | 2017-08-29 | 江苏省中国科学院植物研究所 | One plant of Lycoris aurea endogenetic bacteria bulkholderia cepasea HDXY 02 and its application |
| KR101862993B1 (en) * | 2017-05-19 | 2018-05-30 | 경상대학교산학협력단 | Burkholderia glumae OK001 strain and a method of toxoflavin production using the strain |
| CN111607537A (en) * | 2020-05-15 | 2020-09-01 | 湖北大学 | Preparation method and application of Burkholderia MEL01 for efficiently antagonizing fusarium graminearum |
-
2018
- 2018-11-09 CN CN201811328269.7A patent/CN111172049B/en active Active
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20080051316A (en) * | 2006-12-05 | 2008-06-11 | 재단법인서울대학교산학협력재단 | Toxoflavin herbicide from burkholderia glumae and separation method thereof |
| JPWO2009060882A1 (en) * | 2007-11-09 | 2011-03-24 | 国立大学法人 東京大学 | Amide compounds and bacterial disease control agents for agriculture and horticulture |
| US20140073501A1 (en) * | 2010-02-25 | 2014-03-13 | Marrone Bio Innovations, Inc. | Isolated bacterial strain of the genus burkholderia and pesticidal metabolites therefrom |
| CN105319313A (en) * | 2015-12-09 | 2016-02-10 | 山东出入境检验检疫局检验检疫技术中心 | Liquid chromatogram-tandem mass spectrum detection method of toxoflavin |
| CN105907753A (en) * | 2016-05-25 | 2016-08-31 | 山东出入境检验检疫局检验检疫技术中心 | Burkholderia gladioli molecular standard sample and preparation method thereof |
| KR101862993B1 (en) * | 2017-05-19 | 2018-05-30 | 경상대학교산학협력단 | Burkholderia glumae OK001 strain and a method of toxoflavin production using the strain |
| CN107099478A (en) * | 2017-06-06 | 2017-08-29 | 江苏省中国科学院植物研究所 | One plant of Lycoris aurea endogenetic bacteria bulkholderia cepasea HDXY 02 and its application |
| CN111607537A (en) * | 2020-05-15 | 2020-09-01 | 湖北大学 | Preparation method and application of Burkholderia MEL01 for efficiently antagonizing fusarium graminearum |
Non-Patent Citations (10)
| Title |
|---|
| LI X: ""Burkholderia gladioli strain HDXY-02 16S ribosomal RNA gene， partial sequence", 《GENBANK DATABASE》 * |
| XIAODAN LI 等: "Toxoflavin Produced by Burkholderia gladioli from Lycoris aurea Is a New Broad-Spectrum Fungicide", 《APPLIED & ENVIRONMENTAL MICROBIOLOGY》 * |
| 岳启安等: "椰毒假单胞菌的毒黄素对免疫细胞的毒性及解毒作用研究", 《潍坊医学院学报》 * |
| 李晓丹: "药用植物内生细菌HDXY-02抗真菌物质毒黄素的分离鉴定和合成调控机制", 《中国优秀博士学位论文全文数据库(电子期刊)》 * |
| 杨正时 等编: "《人及动物病原细菌学》", 31 March 2003, 河北科学技术出版社 * |
| 林黎明等: "萃取―分光光度法测定酵米面假单胞菌的毒黄素", 《潍坊医学院学报》 * |
| 田凤丽等: "椰酵伯菌毒黄素的研究进展", 《医学综述》 * |
| 管福来等: "一种固氮菌-唐菖蒲伯克霍尔德氏菌的表型特征", 《潍坊医学院学报》 * |
| 翁晨辉等: "毒黄素的合成、分离及其检测技术研究进展", 《生命科学》 * |
| 辛文芳等: "扎兰屯地区酵米面中毒的病原菌研究", 《生物技术》 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111172050A (en) * | 2018-11-09 | 2020-05-19 | 江苏省中国科学院植物研究所 | Fermentation strategy for high yield of toxoflavin by using Burkholderia |
| CN111172050B (en) * | 2018-11-09 | 2022-05-17 | 江苏省中国科学院植物研究所 | Fermentation strategy for high yield of toxoflavin by using Burkholderia |
| CN111662939A (en) * | 2020-07-24 | 2020-09-15 | 江苏省中国科学院植物研究所 | Method for promoting burkholderia to synthesize toxoflavin by using signal molecules |
| CN111662939B (en) * | 2020-07-24 | 2024-02-13 | 江苏省中国科学院植物研究所 | Method for promoting burkholderia to synthesize toxic flavine by using signal molecules |
Also Published As
| Publication number | Publication date |
|---|---|
| CN111172049B (en) | 2023-05-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2018133399A1 (en) | Method for producing p-hydroxybenzaldehyde using microorganism | |
| CN111154673A (en) | Prodigiosin producing strain and production method and application thereof | |
| CN114806974B (en) | Salmonella strain and application thereof | |
| CN111019866A (en) | Endophytic bacillus of Pu' er tea tree leaves and application thereof | |
| CN111172049B (en) | Strain Huang Sugao producing strain and application thereof | |
| CN115044505A (en) | Antibacterial lipopeptide produced by bacillus belgii and application of antibacterial lipopeptide in cosmetics and foods | |
| Lahoum et al. | Antifungal activity of a Saharan strain of Actinomadura sp. ACD1 against toxigenic fungi and other pathogenic microorganisms | |
| Jiang et al. | Diversity and chemical defense role of culturable non-actinobacterial bacteria isolated from the South China Sea gorgonians | |
| JP6181972B2 (en) | Method for producing aromatic compound | |
| CN108794368A (en) | A kind of alkaloid compound and preparation method and application with various bacteriostatic activity | |
| CN110551659B (en) | Bacillus cereus strain with anti-nematode activity and application thereof | |
| CN104073453B (en) | Bacillus amyloliquefaciens and application thereof in control over geosmin smell in white spirit | |
| CN104004693B (en) | A kind of Bacillus pumilus and the application of earthy in controlling Chinese liquor thereof | |
| CN111662939B (en) | Method for promoting burkholderia to synthesize toxic flavine by using signal molecules | |
| CN105802872B (en) | Pseudomonas fluorescens, method for producing phenazine amide and application thereof | |
| CN110144303B (en) | Piperazine diketone compound, strain, preparation and application | |
| CN104004692B (en) | A kind of bacillus subtilis and the application of earthy in controlling Chinese liquor thereof | |
| CN115491319A (en) | Burkholderia and method for producing FR901464 by fermenting Burkholderia | |
| CN106978457B (en) | Preparation method of antibiotic fusaricidin A | |
| CN113493750B (en) | Marine actinomycetes and application thereof | |
| CN114292193B (en) | Depsipeptide cyclic ether compound, bacterial strain, preparation method and application | |
| CN111979137B (en) | Carbon-phosphorus compound derived from marine streptomyces and preparation method and application thereof | |
| JPS6053597B2 (en) | New antibiotic N-461 substance, its manufacturing method, and agricultural and horticultural fungicides containing it as an active ingredient | |
| JP4380913B2 (en) | Novel FT-0554 substance and production method thereof | |
| CN101709058B (en) | Polyene macrolides compound, preparation and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |